Company intelligence / Profile preview

Piedmont Cancer Institute

Atlanta, Georgia, United States

Ownership: Private
Development stage: Other

Overview

Piedmont Cancer Institute is an independent, physician-led oncology practice providing comprehensive, personalized cancer care using a multidisciplinary team approach. It offers advanced diagnostics, access to clinical trials, and a full suite of patient support services. PCI is a member of the Georgia CORE research network and participates in clinical trials for investigational cancer therapies

Therapeutic areas: HematologyOncology
Modalities: Small moleculeBiologicMonoclonal antibodySystemic chemotherapyTargeted therapyRadiation (referred out)
Industry: Academic Hospital/University/Research

Partnerships

Georgia CORE Research Network

Beyond the preview

Go deeper on Piedmont Cancer Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Piedmont Cancer Institute.

Explore the full profile